Mar 06, 2024 / 06:30PM GMT
Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research Analyst
Good afternoon, everyone. Thanks for being here. Welcome again to TD Cowen's 44th Annual Health Care Conference. My name is Tyler Van Buren, senior biotech analyst here.
For this session, it's a privilege to have a fireside chat with Moderna. And from Moderna, it's my pleasure to introduce Stephen Hoge, President. Stephen, thank you very much for being here.
Stephen Hoge - Moderna, Inc. - President
Thanks for having me, Tyler.
Questions and Answers:
Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research AnalystIf you guys have any questions during the fireside chat, feel free to raise your hand, and I'll do my best to get them asked.
We're going to start with COVID, even though it's becoming -- naturally, but even though it's becoming a smaller part of the story, I feel like we have to start there. So to level set, you guys have mentioned that you'll have $4 billion